share_log

浙江震元(000705.SZ):子公司震元生物在建组氨酸等产品生产线预计今年年底试生产

Zhejiang Zhenyuan (000705.SZ): The subsidiary Zhenyuan Biotech is building a production line for histidine and other products, which is expected to be tested by the end of this year

Gelonghui Finance ·  May 7 04:17

Gelonghui, May 7 | Zhejiang Zhenyuan (000705.SZ) said on the investor interactive platform that the company's subsidiary Zhenyuan Biotech is building production lines for histidine, levodopa, tyrosine and other products, which are expected to be put into trial production by the end of this year and officially put into production in 2025.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment